{"id":"https://openalex.org/W7127624263","doi":"https://doi.org/10.3390/ph19020267","title":"Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes: Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia","display_name":"Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes: Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia","publication_year":2026,"publication_date":"2026-02-04","ids":{"openalex":"https://openalex.org/W7127624263","doi":"https://doi.org/10.3390/ph19020267","pmid":"https://pubmed.ncbi.nlm.nih.gov/41754808"},"language":"en","primary_location":{"id":"doi:10.3390/ph19020267","doi":"https://doi.org/10.3390/ph19020267","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19020267","pdf_url":"https://www.mdpi.com/1424-8247/19/2/267/pdf","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1424-8247/19/2/267/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065019463","display_name":"Janani Sundaresan","orcid":"https://orcid.org/0009-0009-7905-0214","observed_orcids":["https://orcid.org/0009-0009-7905-0214"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Janani Sundaresan","raw_affiliation_strings":["Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"],"raw_orcid":"https://orcid.org/0009-0009-7905-0214","affiliations":[{"raw_affiliation_string":"Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074651259","display_name":"Wout J. Hamelink","orcid":"https://orcid.org/0000-0002-0677-8070","observed_orcids":["https://orcid.org/0000-0002-0677-8070"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wout J. Hamelink","raw_affiliation_strings":["Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076506384","display_name":"Renske C. F. Hebing","orcid":"https://orcid.org/0000-0002-6725-6719","observed_orcids":["https://orcid.org/0000-0002-6725-6719"]},"institutions":[{"id":"https://openalex.org/I4210134551","display_name":"Sint Maartenskliniek","ror":"https://ror.org/0454gfp30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210134551"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Renske C. F. Hebing","raw_affiliation_strings":["Department of Pharmacy, Sint Maartenskliniek, 6574 NA Nijmegen, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-6725-6719","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Sint Maartenskliniek, 6574 NA Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I4210134551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036311537","display_name":"Maartje Miep van de Meeberg","orcid":"https://orcid.org/0000-0003-2415-5114","observed_orcids":["https://orcid.org/0000-0003-2415-5114"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4405254904","display_name":"Amsterdam Gastroenterology Endocrinology Metabolism","ror":"https://ror.org/02ck0dq88","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4405254904"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Maartje van de Meeberg","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, 1105 AZ Amsterdam, The Netherlands","Department of Gastroenterology and Hepatology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, 1105 AZ Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4405254904"]},{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103925626","display_name":"Montse Janssen Bon\u00e1s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103448","display_name":"St. Antonius Ziekenhuis","ror":"https://ror.org/01jvpb595","country_code":"NL","type":"funder","lineage":["https://openalex.org/I4210103448"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Montse Janssen Bon\u00e1s","raw_affiliation_strings":["ILD Center of Excellence (Member of the European Reference Network-Lung), St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ILD Center of Excellence (Member of the European Reference Network-Lung), St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands","institution_ids":["https://openalex.org/I4210103448"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017731507","display_name":"Inge Margriet van der Sluis","orcid":"https://orcid.org/0000-0002-5822-7668","observed_orcids":["https://orcid.org/0000-0002-5822-7668"]},"institutions":[{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Inge M. van der Sluis","raw_affiliation_strings":["Princess M\u00e1xima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-5822-7668","affiliations":[{"raw_affiliation_string":"Princess M\u00e1xima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045760753","display_name":"Pascal H P de Jong","orcid":"https://orcid.org/0000-0001-6628-6222","observed_orcids":["https://orcid.org/0000-0001-6628-6222"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Pascal H. P. de Jong","raw_affiliation_strings":["Department of Rheumatology, Erasmus MC, 3015 GD Rotterdam, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0001-6628-6222","affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Erasmus MC, 3015 GD Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010287896","display_name":"Martijn W. Heymans","orcid":"https://orcid.org/0000-0002-3889-0921","observed_orcids":["https://orcid.org/0000-0002-3889-0921"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Martijn Heymans","raw_affiliation_strings":["Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065493212","display_name":"R\u00f3bert de Jonge","orcid":"https://orcid.org/0000-0002-3454-0094","observed_orcids":["https://orcid.org/0000-0002-3454-0094"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Robert de Jonge","raw_affiliation_strings":["Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-3454-0094","affiliations":[{"raw_affiliation_string":"Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050128764","display_name":"Maurits C. F. J. de Rotte","orcid":"https://orcid.org/0000-0002-9213-107X","observed_orcids":["https://orcid.org/0000-0002-9213-107X"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Maurits C. F. J. de Rotte","raw_affiliation_strings":["Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-9213-107X","affiliations":[{"raw_affiliation_string":"Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036690563","display_name":"Maja Bulatovi\u0107-\u0106alasan","orcid":"https://orcid.org/0000-0002-1053-7739","observed_orcids":["https://orcid.org/0000-0002-1053-7739","https://orcid.org/0000-0002-5899-113X"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Maja Bulatovi\u0107-\u0106alasan","raw_affiliation_strings":["Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands","Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Laboratory of Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5036690563"],"corresponding_institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210151833"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":14.2847,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.98540633,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"19","issue":"2","first_page":"267","last_page":"267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.51419997215271,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.51419997215271,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.06620000302791595,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.03310000151395798,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9039999842643738},{"id":"https://openalex.org/keywords/methotrexate-polyglutamates","display_name":"methotrexate polyglutamates","score":0.9940000176429749},{"id":"https://openalex.org/keywords/immune-mediated-inflammatory-diseases","display_name":"immune-mediated inflammatory diseases","score":0.8519999980926514},{"id":"https://openalex.org/keywords/childhood-acute-lymphoblastic-leukemia","display_name":"childhood acute lymphoblastic leukemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.8149999976158142},{"id":"https://openalex.org/keywords/juvenile-idiopathic-arthritis","display_name":"juvenile idiopathic arthritis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/sarcoidosis","display_name":"sarcoidosis","score":1.0},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.7110000252723694},{"id":"https://openalex.org/keywords/prednisolone","display_name":"prednisolone","score":0.7910000085830688},{"id":"https://openalex.org/keywords/folic-acid","display_name":"folic acid","score":0.7039999961853027},{"id":"https://openalex.org/keywords/disease-modifying-antirheumatic-drugs","display_name":"disease-modifying antirheumatic drugs","score":0.9150000214576721},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.3050000071525574}],"concepts":[{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.9179999828338623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8860999941825867},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.6875},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5751000046730042},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4900999963283539},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.4887999892234802},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.48240000009536743},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.3978999853134155},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.39329999685287476},{"id":"https://openalex.org/C2781382166","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Antifolate","level":4,"score":0.38260000944137573},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.35830000042915344},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3492000102996826},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3490999937057495},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.3160000145435333},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.3066999912261963},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.303600013256073},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29829999804496765},{"id":"https://openalex.org/C2776390293","wikidata":"https://www.wikidata.org/wiki/Q2035485","display_name":"Subcutaneous injection","level":2,"score":0.29510000348091125},{"id":"https://openalex.org/C2992130864","wikidata":"https://www.wikidata.org/wiki/Q127060","display_name":"Folic acid","level":2,"score":0.2775999903678894},{"id":"https://openalex.org/C2909344506","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Folic Acid Antagonists","level":3,"score":0.2759999930858612},{"id":"https://openalex.org/C2776863199","wikidata":"https://www.wikidata.org/wiki/Q976388","display_name":"Acute leukemia","level":3,"score":0.2736999988555908},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.26989999413490295},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.2669000029563904},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.25999999046325684},{"id":"https://openalex.org/C2778685788","wikidata":"https://www.wikidata.org/wiki/Q415734","display_name":"Aminopterin","level":3,"score":0.25760000944137573},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.25699999928474426},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2554999887943268},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25200000405311584}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3390/ph19020267","doi":"https://doi.org/10.3390/ph19020267","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19020267","pdf_url":"https://www.mdpi.com/1424-8247/19/2/267/pdf","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},{"id":"pmid:41754808","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41754808","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals (Basel, Switzerland)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:35e00487c71747629ac777df9ac23bcb","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/35e00487c71747629ac777df9ac23bcb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceuticals, Vol 19, Iss 2, p 267 (2026)","raw_type":"article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/469572","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/469572","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12943293","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12943293/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceuticals (Basel)","raw_type":"Text"},{"id":"pmh:oai:pure.eur.nl:openaire/05bc9417-36c6-43f4-9c26-2475c24456f8","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/05bc9417-36c6-43f4-9c26-2475c24456f8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Sundaresan, J, Hamelink, W J, Hebing, R C F, van de Meeberg, M, Janssen Bon\u00e1s, M, van der Sluis, I M, de Jong, P H P, Heymans, M, de Jonge, R, de Rotte, M C F J & Bulatovi\u0107-\u0106alasan, M 2026, 'Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes : Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia', Pharmaceuticals, vol. 19, no. 2, 267. https://doi.org/10.3390/ph19020267","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3390/ph19020267","doi":"https://doi.org/10.3390/ph19020267","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19020267","pdf_url":"https://www.mdpi.com/1424-8247/19/2/267/pdf","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8604294657707214,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7127624263.pdf","grobid_xml":"https://content.openalex.org/works/W7127624263.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W612972800","https://openalex.org/W1623985254","https://openalex.org/W1971473080","https://openalex.org/W1980524534","https://openalex.org/W1987487114","https://openalex.org/W2026636233","https://openalex.org/W2035029649","https://openalex.org/W2051185856","https://openalex.org/W2061523691","https://openalex.org/W2073104311","https://openalex.org/W2099793101","https://openalex.org/W2102076856","https://openalex.org/W2104729127","https://openalex.org/W2117434167","https://openalex.org/W2133600149","https://openalex.org/W2137515243","https://openalex.org/W2300953564","https://openalex.org/W2313836274","https://openalex.org/W2539871382","https://openalex.org/W2563857970","https://openalex.org/W2606815103","https://openalex.org/W2623081002","https://openalex.org/W2742722472","https://openalex.org/W2751533907","https://openalex.org/W2757354840","https://openalex.org/W2804884913","https://openalex.org/W2955773501","https://openalex.org/W3005664296","https://openalex.org/W3042145992","https://openalex.org/W3087350931","https://openalex.org/W3090721368","https://openalex.org/W3118793607","https://openalex.org/W3120198970","https://openalex.org/W3127970713","https://openalex.org/W3158206629","https://openalex.org/W3201595862","https://openalex.org/W4200517403","https://openalex.org/W4288748796","https://openalex.org/W4294032315","https://openalex.org/W4308053630","https://openalex.org/W4312061426","https://openalex.org/W4379229582","https://openalex.org/W4380576251","https://openalex.org/W4387114855","https://openalex.org/W4387115926","https://openalex.org/W4388728557","https://openalex.org/W4393989422","https://openalex.org/W4400424639"],"related_works":[],"abstract_inverted_index":{"Background/Objectives:":[0],"Methotrexate":[1,30],"(MTX)":[2],"is":[3,204],"a":[4],"cornerstone":[5],"drug":[6],"used":[7,170],"to":[8,43,66,163,208,231],"treat":[9],"immune-mediated":[10],"inflammatory":[11],"diseases":[12],"(IMIDs)":[13],"in":[14,21,34,48,157,171,213],"low":[15],"doses":[16,23,156],"(10\u201330":[17],"mg/week),":[18],"and":[19,52,65,70,91,139,193,215,244,251],"malignancies":[20],"high":[22],"(5000":[24],"mg/m2/2":[25],"weeks).":[26],"Its":[27],"active":[28],"metabolites,":[29],"polyglutamates":[31],"(MTX-PG2\u20135),":[32],"quantified":[33],"erythrocytes,":[35],"are":[36],"associated":[37,188],"with":[38,50,59,82,166,189,198,226],"efficacy.":[39],"This":[40,203,236],"study":[41,207,237],"aimed":[42],"compare":[44,209],"erythrocyte":[45,210],"MTX-PG":[46,96,176,211,258],"concentrations":[47,160,192,228],"patients":[49,81],"IMIDs":[51],"pediatric":[53],"acute":[54],"lymphoblastic":[55],"leukemia":[56],"(ped-ALL)":[57],"treated":[58],"low-dose":[60,168,214,232],"or":[61],"high-dose":[62,148,216,219],"MTX,":[63],"respectively,":[64],"identify":[67],"clinical,":[68],"demographic,":[69],"treatment-related":[71],"factors":[72],"influencing":[73],"their":[74],"concentration.":[75],"Methods:":[76],"A":[77],"total":[78],"of":[79,109,129,133,241],"567":[80],"rheumatoid":[83],"arthritis,":[84,87],"juvenile":[85],"idiopathic":[86],"Crohn\u2019s":[88],"disease,":[89],"sarcoidosis,":[90],"ped-ALL":[92,107],"were":[93,161],"included.":[94],"Erythrocyte":[95],"concentration":[97,212],"data":[98],"was":[99,144,187],"collected":[100],"after":[101],"3":[102],"months":[103,105],"(2.5":[104],"for":[106,116],"patients)":[108],"MTX-use.":[110],"Multivariate":[111],"linear":[112],"regressing":[113],"modelling":[114],"adjusting":[115],"age,":[117,243],"sex,":[118],"body":[119],"mass":[120],"index":[121],"(BMI),":[122],"smoking":[123],"status,":[124],"starting":[125],"MTX":[126,130,149,169,220,234],"dose,":[127],"route":[128,240],"administration,":[131,242],"use":[132,180,186],"predniso(lo)ne,":[134,250],"disease-modifying":[135],"anti-rheumatic":[136],"drugs":[137],"(DMARDs),":[138],"folic":[140,194,252],"(or":[141,195,253],"folinic)":[142,196,254],"acid":[143,197,255],"performed.":[145],"Results:":[146],"Intravenous":[147,218],"increased":[150,222],"MTX-PG4&5":[151,191,224],"accumulation.":[152],"Despite":[153],"50-fold":[154],"higher":[155,190,199],"ped-ALL,":[158],"MTX-PG2\u20135sum":[159,227],"similar":[162,229],"those":[164],"seen":[165],"subcutaneous":[167,233],"IMIDs.":[172],"Age":[173],"positively":[174],"influenced":[175],"concentrations,":[177,225],"while":[178],"DMARD":[179],"reduced":[181],"MTX-PG2\u20133&5":[182],"concentrations.":[183,201,259],"Interestingly,":[184],"predniso(lo)ne":[185],"MTX-PG3\u20135":[200],"Conclusions:":[202],"the":[205],"first":[206],"patients.":[217],"administration":[221],"long-chain":[223],"compared":[230],"use.":[235],"demonstrated":[238],"that":[239],"concomitant":[245],"therapies":[246],"such":[247],"as":[248],"DMARDs,":[249],"significantly":[256],"influence":[257]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2026-02-06T00:00:00"}